www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Bull-Lifshitz-LLP-Announces-Investigation-of-the-Acquisition-of-Facet-Biotech-Corporation-by-Abbott-Laboratories-756684 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Bull Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Facet Biotech ...http://www.finanzen.net/nachricht/Bull-Lifshitz-LLP-Announces-Investigation-of-the-Acquisition-of-Facet-Biotech-Corporation-by-Abbott-Laboratories-756684http://www.finanzen.net/nachricht/Kendall-Law-Group-Investigates-Facet-Biotech-Corporation-Merger-for-Shareholders-755387 Kendall Law Group, a national securities litigation firm is investigating Facet Biotech Corporation (NASDAQ: FACT) for shareholders in connection to the proposed sale of the Company to Abbott Laboratories. If you are ...http://www.finanzen.net/nachricht/Kendall-Law-Group-Investigates-Facet-Biotech-Corporation-Merger-for-Shareholders-755387http://www.finanzen.net/nachricht/Law-Offices-of-Howard-G-Smith-Announces-Investigation-on-Behalf-of-Shareholders-of-Facet-Biotech-Corporation-755197 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Facet Biotech Corporation ...http://www.finanzen.net/nachricht/Law-Offices-of-Howard-G-Smith-Announces-Investigation-on-Behalf-of-Shareholders-of-Facet-Biotech-Corporation-755197http://www.finanzen.net/nachricht/Levi-Korsinsky-LLP-Investigates-Possible-Breach-of-Fiduciary-Duty-by-the-Board-of-Facet-Biotech-Corporation-FACT-754798 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Levi Korsinsky is investigating the Board of Directors of Facet Biotech Corporation ("Facet Biotech” or the "Company”) (NasdaqGM: FACT) for ...http://www.finanzen.net/nachricht/Levi-Korsinsky-LLP-Investigates-Possible-Breach-of-Fiduciary-Duty-by-the-Board-of-Facet-Biotech-Corporation-FACT-754798http://www.finanzen.net/nachricht/Facet-Biotech-and-Bristol-Myers-Squibb-Report-Promising-Phase-I-II-Interim-Data-for-Elotuzumab-in-Patients-with-Relapsed-Multiple-Myeloma-712457 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Facet Biotech Corporation (Nasdaq: FACT) and Bristol-Myers Squibb Company (NYSE: BMY) announced that potentially promising data from a Phase ...http://www.finanzen.net/nachricht/Facet-Biotech-and-Bristol-Myers-Squibb-Report-Promising-Phase-I-II-Interim-Data-for-Elotuzumab-in-Patients-with-Relapsed-Multiple-Myeloma-712457http://www.finanzen.net/nachricht/Biogen-Idec-legt-Uebernahmeangebot-fuer-Facet-Biotech-vor-673123 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Wie Biogen Idec (NASDAQ:BIIB) heute mitteilte, hat die FBC Acquisition Corp., ein hundertprozentiges ...http://www.finanzen.net/nachricht/Biogen-Idec-legt-Uebernahmeangebot-fuer-Facet-Biotech-vor-673123http://www.finanzen.net/nachricht/Biogen-Idec-Commences-Tender-Offer-for-Facet-Biotech-672856 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, ...http://www.finanzen.net/nachricht/Biogen-Idec-Commences-Tender-Offer-for-Facet-Biotech-672856http://www.finanzen.net/nachricht/Wolf-Haldenstein-Investigates-Facet-Biotech-Offer-Rejection-666117 <style type="text/css"> <!-- .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin {margin-bottom: 0px; margin-top: 0px} .bwtablebottommargin {margin-bottom: ...http://www.finanzen.net/nachricht/Wolf-Haldenstein-Investigates-Facet-Biotech-Offer-Rejection-666117http://www.finanzen.net/nachricht/aktien/First-Albany-Companies-to-Be-Renamed-Broadpoint-Announces-Change-in-NASDAQ-Trading-Symbol-247596First Albany Companies Inc. (NASDAQ: FACT), to be renamed Broadpoint Securities Group, Inc., today announced that its trading symbol, currently "FACT”, will change to "BPSG” effective upon the open of business, Monday, November ...http://www.finanzen.net/nachricht/aktien/First-Albany-Companies-to-Be-Renamed-Broadpoint-Announces-Change-in-NASDAQ-Trading-Symbol-247596http://www.finanzen.net/nachricht/aktien/First-Albany-Companies-to-Be-Renamed-Broadpoint-Securities-Group-Announces-Third-Quarter-Results-and-Commences-Rebuilding-Process-243260First Albany Companies Inc. (NASDAQ: FACT) reported its financial results for the third quarter ending September 30, 2007 and will hold a conference call today at 10 A.M. EDT (see Conference Call Information below) to discuss these ...http://www.finanzen.net/nachricht/aktien/First-Albany-Companies-to-Be-Renamed-Broadpoint-Securities-Group-Announces-Third-Quarter-Results-and-Commences-Rebuilding-Process-243260